UFLEX LTD. - 500148 - Audited Financial Results (Standalone & Consolidated) For The Quarter And Year Ended 31St March, 2020
Audited Financial Results (Standalone & Consolidated) for the Quarter and Year Ended 31st March, 202030-06-2020
UFLEX LTD. - 500148 - Audited Financial Results (Standalone & Consolidated) For The Quarter And Year Ended 31St March, 2020
Audited Financial Results (Standalone & Consolidated) for the Quarter and Year Ended 31st March, 2020UFLEX LTD. - 500148 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Conference Call under the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015UFLEX LTD. - 500148 - Board to consider FY20 results & DIvidend on June 30, 2020
Uflex Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on June 30, 2020 inter-alia:1. To consider and approve the Standalone & Consolidated Audited Financial Statements of the Company for the quarter and financial year ended March 31, 2020.2. To consider and recommend the payment of dividend, if any, subject to the approval of Members of the Company. The dividend, if so recommended by the Board and approved by the Members at the forthcoming Annual General Meeting of the Company will be payable on or after the date of Annual General Meeting.Pursuant to the "UFLEX Limited Code to regulate, monitor and report trading by Directors, Promoters, Designated Employees and Connected Persons of the Company", the Trading Window Close Period has commenced from 1st April, 2020 and will end 48 hours after the results are made public on June 30, 2020.UFLEX LTD. - 500148 - Board Meeting Intimation for To Consider And Approve The Standalone & Consolidated Audited Financial Statements Of The Company For The Quarter And Financial Year Ended 31St March, 2020
UFLEX LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2020 ,inter alia, to consider and approve To consider and approve the Standalone & Consolidated Audited Financial Statements of the Company for the quarter and financial year ended 31st March, 2020Uflex saysCOVID-19 may propel development of sterile, anti-microbial packaging solutions
Uflex revenues could grow 12-15% in FY21, as new projects are commissioned during the year, Rajesh Bhatia, Group President (Finance Accounts) CFO UFlex told MoneycontrolUFLEX LTD. - 500148 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 18, 2020 for Anshika Consultants Pvt LtdUFLEX LTD. - 500148 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificate received under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulation,20I5.UFLEX LTD. - 500148 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June13, 2020 for Anshika Consultants Pvt Ltd